Sugi Predict

Sugi Predict / Compounds / SCHEMBL186958

SCHEMBL186958

SCHEMBL186958

O=C(O)C(COP(=O)(O)O)OP(=O)(O)OP(=O)(O)O

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ PGK1 P00558 1/20 0.50
▸ PGK2 P07205 1/20 0.50
▸ PGD P52209 3/20 0.47
▸ MVD P53602 3/20 0.38
▸ MPI P34949 1/20 0.35
▸ BTN3A1 O00481 1/20 0.34
▸ LAP3 P28838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4404352 0.84 PGK1 (0.57) PGK1PGK2PGDMPILAP3
SCHEMBL30852238 0.84 PGK1 (0.57) PGK1PGK2PGDMPILAP3
SCHEMBL80335 0.84 PGK1 (0.57) PGK1PGK2PGDMPILAP3
SCHEMBL31657225 0.82 PGK1 (0.55) PGK1PGK2PGDMPILAP3
Phosphoric Acid SCHEMBL5917775 0.82 PGK1 (0.55) PGK1PGK2PGDMPILAP3
SCHEMBL7756355 0.82 PGK1 (0.47) PGK1PGK2PGDLAP3
SCHEMBL78575 0.81 MVD (0.36) PGK1PGK2PGDMVDBTN3A1
Arsenic SCHEMBL27787228 0.79 MVD (0.35) PGK1PGK2PGDMVDBTN3A1
SCHEMBL13176646 0.79 PGK1 (0.52) PGK1PGK2PGDMPILAP3
SCHEMBL3488353 0.79 PGK1 (0.45) PGK1PGK2PGDLAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041286-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2012-02-16 — — US disclosed
US-20120041285-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2012-02-16 — — US disclosed
US-20120041287-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2012-02-16 — — US disclosed
US-20120010481-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2012-01-12 — — US disclosed
EP-2401005-A1 SYSTEMS, DEVICES, AND METHODS INCLUDING INFECTION-FIGHTING AND MONITORING SHUNTS Searete LLC (US) 2012-01-04 — — EP disclosed
US-20110275912-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-11-10 — — US disclosed
US-20110208021-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC 2011-08-25 — — US disclosed
US-20110208026-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC 2011-08-25 — — US disclosed
US-20110208023-A1 Systems, devices, and methods including implantable devices with anti-microbial properties SEARETE LLC 2011-08-25 — — US disclosed
US-20110160644-A1 Systems, devices, and methods including catheters configured to release ultraviolet energy absorbing agents SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-30 — — US disclosed
US-20110160643-A1 Systems, devices, and methods including catheters having acoustically actuatable waveguide components for delivering a sterilizing stimulus to a region proximate a surface of the catheter SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-30 — — US disclosed
US-20110160681-A1 Systems, devices, and methods including catheters having light removable coatings based on a sensed condition SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-30 — — US disclosed
US-20110152978-A1 Systems, devices, and methods including catheters configured to monitor biofilm formation having biofilm spectral information configured as a data structure SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-23 — — US disclosed
US-20110152751-A1 Systems, devices, and methods including catheters having UV-Energy emitting coatings SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-23 — — US disclosed
US-20110152790-A1 Systems, devices, and methods including catheters having self-cleaning surfaces SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-23 — — US disclosed
US-20110152750-A1 Systems devices, and methods including catheters configured to monitor and inhibit biofilm formation SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-23 — — US disclosed
US-20110152752-A1 Systems, devices, and methods including catheters having components that are actively controllable between transmissive and reflective states SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-23 — — US disclosed
US-20110152789-A1 Systems, devices, and methods including catheters having components that are actively controllable between two or more wettability states SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-23 — — US disclosed
US-20110144566-A1 Systems, devices, and methods including catheters having an actively controllable therapeutic agent delivery component SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE 2011-06-16 — — US disclosed
WO-2011068545-A1 SYSTEMS, DEVICES, AND METHODS INCLUDING CATHETERS CONFIGURED TO MONITOR AND INHIBIT BIOFILM FORMATION SEARETE LLC (US) 2011-06-09 — — WO disclosed